Today: 2 May 2026
Goldman Sachs stock climbs after hours as IPO boom talk and U.S. data week collide
10 February 2026
1 min read

Goldman Sachs stock climbs after hours as IPO boom talk and U.S. data week collide

New York, Feb 9, 2026, 18:33 ET — After-hours

  • Goldman shares pushed higher in late trading, with Wall Street finding its footing again following last week’s tech stumble.
  • Goldman now sees the 2026 IPO market swelling, drawing attention once again to deal fees.
  • Next up for rate-cut wagers: jobs and inflation numbers due out later this week.

The Goldman Sachs Group, Inc. (GS) climbed 1.6% to $943.62 after hours on Monday. Shares traded in a range from $922.42 up to $949.00 throughout the session. Roughly 2.3 million shares changed hands.

U.S. stocks bounced back, with tech shares out in front and Treasury yields pulling back as investors braced for a packed week of economic releases. The S&P 500 gained 0.58%, the Nasdaq climbed 1.02%, and the 10-year Treasury yield settled near 4.202%. “It seems to be the traditional buy-the-dip by retail investors,” said Oliver Pursche, senior vice president and adviser at Wealthspire Advisors. Reuters

Goldman thrust dealmaking into the spotlight again. The bank’s analysts projected that U.S. IPO proceeds might hit $160 billion by 2026—a fourfold jump—with the number of offerings potentially climbing to 120. SpaceX, OpenAI, and Anthropic are among those edging closer to public markets. Still, they flagged risks: “continued volatility in share prices” and a backlog dominated by software IPOs could cloud the picture. Reuters

Other major banks saw mixed action late. Morgan Stanley picked up 1.3%. JPMorgan dipped 0.1%, and Bank of America edged lower by 0.3%.

Goldman cares about IPOs since advisory and underwriting fees usually track with both equity valuations and how upbeat companies feel. In an IPO—a private company’s initial public share sale—banks collect a cut of the raised cash as their fee.

The competition is heating up. Morgan Stanley has reinstated longtime tech dealmaker Michael Grimes as chairman of investment banking, according to an internal memo reviewed by Reuters, aiming to secure major tech IPOs.

Interest rates remain a wild card. White House economic adviser Kevin Hassett told reporters he expects “slightly smaller job numbers” in the months ahead but said investors “shouldn’t panic” if payrolls come in soft—he pointed to productivity gains and a cooler labor force as factors. According to a Reuters survey referenced in the report, economists put January’s job creation at 70,000 and forecast the unemployment rate holding at 4.4%. Reuters

Still, things can shift in a hurry. A hotter-than-expected inflation print and a spike in yields, and suddenly firms are pushing IPOs back. Banks could see risk appetite vanish just as fast as it reappeared.

Traders won’t have to wait long for the next data points. The U.S. Bureau of Labor Statistics lists the January Employment Situation report for release Wednesday at 8:30 a.m. ET, with January’s consumer price index coming Friday, also at 8:30 a.m. ET.

Stock Market Today

  • MercadoLibre (MELI) Valuation Check: Is the Stock Undervalued?
    May 2, 2026, 3:13 AM EDT. MercadoLibre's stock closed at $1,850.05, showing mixed returns with a 7.63% rise in one month and 18.88% over one year. The company posted $28.9 billion in revenue and $2 billion in net income, operating across Latin America. Analysts suggest the stock may be 24.2% undervalued, with a fair value estimate of $2,439.88, driven by growth in user engagement and AI-enhanced operating leverage. However, risks include heavy marketing and logistics spending, and credit concerns in Brazil and Argentina. Despite a current P/E ratio of 47x, above industry average, the debate remains if the market has priced in future growth or if there's more upside potential.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 02.05.2026

2 May 2026
LIVEMarkets rolling coverageStarted: May 2, 2026, 12:00 AM EDTUpdated: May 2, 2026, 3:14 AM EDT MercadoLibre (MELI) Valuation Check: Is the Stock Undervalued? May 2, 2026, 3:13 AM EDT. MercadoLibre's stock closed at $1,850.05, showing mixed returns with a 7.63% rise in one month and 18.88% over one year. The company posted $28.9 billion in revenue and $2 billion in net income, operating across Latin America. Analysts suggest the stock may be 24.2% undervalued, with a fair value estimate of $2,439.88, driven by growth in user engagement and AI-enhanced operating leverage. However, risks include heavy marketing and logistics spending, and
US Stock Market Today After Hours: Nasdaq Tops 25,000 As S&P 500 Hits Record High

US Stock Market Today After Hours: Nasdaq Tops 25,000 As S&P 500 Hits Record High

2 May 2026
Nasdaq 100 futures climbed 0.68% and S&P 500 futures edged up 0.06% in early after-hours trading Friday, while Dow futures slipped 0.48%. The S&P 500 and Nasdaq closed at record highs, driven by first-quarter S&P 500 profit growth of 27.8%, according to LSEG. Oil prices, inflation signals, and upcoming jobs data remain in focus. GameStop shares rose 4% after reports it was preparing an offer for eBay.
McDonald’s Corporation Stock Slides Before Earnings as Its Big Drink Bet Comes Due

McDonald’s Corporation Stock Slides Before Earnings as Its Big Drink Bet Comes Due

2 May 2026
McDonald’s shares fell 2.37% to $286.64 on Friday, underperforming rivals ahead of its May 7 earnings report and a U.S. launch of six new McCafé specialty drinks. The company will begin selling the drinks nationwide on May 6, adding beverage specialist roles at 14,000 restaurants. Investors are watching whether the new drinks and value offers can boost traffic without slowing service or hurting margins.
PayPal stock price rebounds as Cantor slashes target and Wall Street looks to CEO handover
Previous Story

PayPal stock price rebounds as Cantor slashes target and Wall Street looks to CEO handover

Quince Therapeutics (QNCX) stock slides before the bell after LifeSci Capital deal review move
Next Story

Quince Therapeutics (QNCX) stock slides before the bell after LifeSci Capital deal review move

Go toTop